Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell
• Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
Roth MKM Maintains Buy Rating for ProSomnus: Here’s What You Need To Know
Roth MKM has decided to maintain its Buy rating of ProSomnus (NASDAQ:OSA) and lower its price target from…
ProSomnus Raises $10M To Fuel Growth And Optimize Operations
ProSomnus, Inc. (NASDAQ: OSA) (the "Company"), a leading CPAP alternative for the treatment of Obstructive Sleep Apnea ("OSA"), today announced the completion of a $10
EXCLUSIVE: Sleep Disorder Focused ProSomnus Raises $10M To Fuel Growth, Optimize Operations
ProSomnus Inc (NASDAQ: OSA) has completed a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital.
ProSomnus's Executive Chair, CEO, and CFO are also participating in the financing.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 150 companies set new 52-week lows.
EXCLUSIVE: ProSomnus’ Device Therapy Better Than Philip’s Device(s) For Sleep-Related Breathing Disorder, Study Shows
ProSomnus Inc (NASDAQ: OSA), a provider of CPAP alternatives for Obstructive Sleep Apnea, announced updated data presented at the ProSleep Conference earlier this month.
The updated data indicate the FLOSAT study is on track to achieve all endpoints.
Why Avalo Therapeutics Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
Gainers
Avalo Therapeutics Inc’s (NASDAQ: AVTX) shares surged 24.99% to 14.5 cents in pre-market trading after the company reported higher-than-expected quarterly earnings earlier this month.
EXCLUSIVE: ProSomnus Reports Much Smaller Than Expected Q2 Loss, Revenues Inline With Consensus
Obstructive Sleep Apnea treatment provider ProSomnus Inc (NASDAQ: OSA) reported Q2 revenues of $6.9 million, up 43% Y/Y and a sequential revenue increase of 19%, slightly beating the consensus of $6.4 million.